{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "BRCA",
      "Cancer",
      "Laparoscopy",
      "Morbidity"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28479170",
  "DateCompleted": {
    "Year": "2018",
    "Month": "02",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "12",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2017",
        "Month": "05",
        "Day": "04"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jmig.2017.04.017",
      "S1553-4650(17)30283-2"
    ],
    "Journal": {
      "ISSN": "1553-4669",
      "JournalIssue": {
        "Volume": "24",
        "Issue": "5",
        "PubDate": {
          "Year": "2017",
          "Season": "Jul-Aug"
        }
      },
      "Title": "Journal of minimally invasive gynecology",
      "ISOAbbreviation": "J Minim Invasive Gynecol"
    },
    "ArticleTitle": "Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience.",
    "Pagination": {
      "StartPage": "837",
      "EndPage": "842",
      "MedlinePgn": "837-842"
    },
    "Abstract": {
      "AbstractText": [
        "To investigate the incidence and predictive factors of 30-day surgery-related morbidity and occult precancerous and cancerous conditions for women undergoing risk-reducing surgery.",
        "A prospective study (Canadian Task Force classification II-1).",
        "A gynecologic oncology referral center.",
        "Breast-related cancer antigen (BRCA) mutation carriers and BRCAX patients (those with a significant family history of breast and ovarian cancer).",
        "Minimally invasive risk-reduction surgery.",
        "Overall, 85 women underwent risk-reducing surgery: 30 (35%) and 55 (65%) had hysterectomy plus bilateral salpingo-oophorectomy (BSO) and BSO alone, respectively. Overall, in 6 (7%) patients, the final pathology revealed unexpected cancer: 3 early-stage ovarian/fallopian tube cancers, 2 advanced-stage ovarian cancers (stage IIIA and IIIB), and 1 serous endometrial carcinoma. Additionally, 3 (3.6%) patients had incidental finding of serous tubal intraepithelial carcinoma. Four (4.7%) postoperative complications within 30\u00a0days from surgery were registered, including fever (n\u00a0=\u00a03) and postoperative ileus (n\u00a0=\u00a01); no severe (grade 3 or more) complications were observed. All complications were managed conservatively. The presence of occult cancer was the only factor predicting the development of postoperative complications (p\u00a0=\u00a0.02).",
        "Minimally invasive risk-reducing surgery is a safe and effective strategy to manage BRCA mutation carriers. Patients should benefit from an appropriate counseling about the high prevalence of undiagnosed cancers observed at the time of surgery."
      ],
      "CopyrightInformation": "Copyright \u00a9 2017 AAGL. Published by Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gynecologic Oncology, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Bogani",
        "ForeName": "Giorgio",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Statistics, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Tagliabue",
        "ForeName": "Elena",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gynecologic Oncology, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Signorelli",
        "ForeName": "Mauro",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gynecologic Oncology, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Chiappa",
        "ForeName": "Valentina",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Human Pathology, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Carcangiu",
        "ForeName": "Maria Luisa",
        "Initials": "ML"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Human Pathology, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Paolini",
        "ForeName": "Biagio",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Gynecologic Surgery Unit, Mayo Clinic, Rochester, Minnesota."
          }
        ],
        "LastName": "Casarin",
        "ForeName": "Jvan",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gynecologic Oncology, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Scaffa",
        "ForeName": "Cono",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Breast Surgery Unit, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Gennaro",
        "ForeName": "Massimiliano",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gynecologic Oncology, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Martinelli",
        "ForeName": "Fabio",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gynecologic Oncology, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Borghi",
        "ForeName": "Chiara",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gynecologic Oncology, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Ditto",
        "ForeName": "Antonino",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gynecologic Oncology, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy. Electronic address: domenica.lorusso@istitutotumori.mi.it."
          }
        ],
        "LastName": "Lorusso",
        "ForeName": "Domenica",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gynecologic Oncology, Istituto di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy."
          }
        ],
        "LastName": "Raspagliesi",
        "ForeName": "Francesco",
        "Initials": "F"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Minim Invasive Gynecol",
    "NlmUniqueID": "101235322",
    "ISSNLinking": "1553-4650"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control"
      ],
      "DescriptorName": "Cystadenocarcinoma, Serous"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control"
      ],
      "DescriptorName": "Fallopian Tube Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "adverse effects",
        "methods"
      ],
      "DescriptorName": "Hysterectomy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Incidence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "adverse effects",
        "statistics & numerical data"
      ],
      "DescriptorName": "Minimally Invasive Surgical Procedures"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Morbidity"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control"
      ],
      "DescriptorName": "Ovarian Neoplasms"
    },
    {
      "QualifierName": [
        "adverse effects",
        "methods"
      ],
      "DescriptorName": "Ovariectomy"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Postoperative Complications"
    },
    {
      "QualifierName": [
        "adverse effects",
        "methods",
        "statistics & numerical data"
      ],
      "DescriptorName": "Prophylactic Surgical Procedures"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Assessment"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Reduction Behavior"
    },
    {
      "QualifierName": [
        "adverse effects",
        "methods"
      ],
      "DescriptorName": "Salpingo-oophorectomy"
    }
  ]
}